Intuitive Surgical, Inc. $ISRG Stock: Phoenix Financial Ltd. Grows Stake

Phoenix Financial Ltd. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 30.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,657 shares of the medical equipment provider’s stock after buying an additional 2,940 shares during the quarter. Phoenix Financial Ltd.’s holdings in Intuitive Surgical were worth $4,861,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Bank of America Corp DE lifted its holdings in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after buying an additional 116,292 shares during the period. Bank of New York Mellon Corp bought a new stake in Intuitive Surgical during the 2nd quarter valued at $1,335,753,000. Amundi increased its holdings in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after acquiring an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Intuitive Surgical by 10.8% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after acquiring an additional 184,044 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded up $3.70 during mid-day trading on Friday, hitting $443.59. The stock had a trading volume of 1,604,248 shares, compared to its average volume of 2,787,457. The firm has a market cap of $153.77 billion, a PE ratio of 53.64, a PEG ratio of 3.03 and a beta of 1.45. The company has a 50 day moving average of $417.59 and a two-hundred day moving average of $429.98. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the previous year, the firm posted $2.40 EPS. The firm’s revenue was up 21.7% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently commented on ISRG shares. Barclays reissued an “overweight” rating and issued a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Wednesday, October 21st. Finally, BTIG Research restated a “buy” rating and issued a $454.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Insiders Place Their Bets

In related news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the completion of the sale, the executive vice president owned 6,236 shares of the company’s stock, valued at $2,857,023.40. The trade was a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the company’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 39,456 shares of company stock valued at $17,769,124. Insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.